CareDx [CDNA] vs Danaher [DHR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: CareDx Inc. wins in 6 metrics, Danaher Corporation wins in 13 metrics, with 0 ties. Danaher Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CareDx Inc. | Danaher Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.98 | 34.61 | CareDx Inc. |
| Price-to-Book Ratio | 3.37 | 2.40 | Danaher Corporation |
| Debt-to-Equity Ratio | 8.64 | 37.17 | CareDx Inc. |
| PEG Ratio | -0.13 | 3.84 | Danaher Corporation |
| EV/EBITDA | -112.43 | 17.69 | Danaher Corporation |
| Profit Margin (TTM) | -5.62% | 14.89% | Danaher Corporation |
| Operating Margin (TTM) | -3.49% | 22.94% | Danaher Corporation |
| EBITDA Margin (TTM) | N/A | 22.94% | N/A |
| Return on Equity | -6.27% | 7.08% | Danaher Corporation |
| Return on Assets (TTM) | -3.15% | 4.19% | Danaher Corporation |
| Free Cash Flow (TTM) | $35.44M | $5.26B | Danaher Corporation |
| Dividend Yield | N/A | 0.56% | N/A |
| 1-Year Return | 34.31% | -3.81% | CareDx Inc. |
| Price-to-Sales Ratio (TTM) | 2.71 | 5.10 | CareDx Inc. |
| Enterprise Value | $876.39M | $140.38B | Danaher Corporation |
| EV/Revenue Ratio | 2.31 | 5.67 | CareDx Inc. |
| Gross Profit Margin (TTM) | 67.24% | 60.34% | CareDx Inc. |
| Revenue per Share (TTM) | $7 | $35 | Danaher Corporation |
| Earnings per Share (Diluted) | $-0.40 | $5.16 | Danaher Corporation |
| Beta (Stock Volatility) | 2.54 | 0.99 | Danaher Corporation |
| Short % of Float | 12.84% | 1.10% | Danaher Corporation |
CareDx Inc. vs Danaher Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CareDx Inc. | 1.06% | 2.46% | 5.30% | 17.71% | 26.55% | 15.31% |
| Danaher Corporation | 1.16% | 1.91% | 1.19% | -14.51% | -22.28% | -23.56% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CareDx Inc. | 34.31% | 180.69% | -71.81% | 399.34% | 128.20% | 128.20% |
| Danaher Corporation | -3.81% | -12.18% | -14.95% | 176.52% | 423.71% | 744.91% |
Performance & Financial Health Analysis: CareDx Inc. vs Danaher Corporation
| Metric | CDNA | DHR |
|---|---|---|
| Market Information | ||
| Market Cap | $1.09B | $126.39B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 886,607 | 5,174,666 |
| 90 Day Avg. Volume | 701,069 | 4,357,215 |
| Last Close | $22.30 | $178.15 |
| 52 Week Range | $10.96 - $23.24 | $160.93 - $242.80 |
| % from 52W High | -4.02% | -26.63% |
| All-Time High | $99.83 (Jan 18, 2021) | $296.06 (Sep 06, 2021) |
| % from All-Time High | -77.66% | -39.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.25% | 0.04% |
| Quarterly Earnings Growth | 0.25% | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.15% |
| Operating Margin (TTM) | -0.03% | 0.23% |
| Return on Equity (TTM) | -0.06% | 0.07% |
| Debt to Equity (MRQ) | 8.64 | 37.17 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.95 | $74.32 |
| Cash per Share (MRQ) | $3.46 | $8.06 |
| Operating Cash Flow (TTM) | $42.03M | $6.44B |
| Levered Free Cash Flow (TTM) | $45.75M | $4.57B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.56% |
| Last 12-Month Dividend | N/A | $1.28 |
Valuation & Enterprise Metrics Analysis: CareDx Inc. vs Danaher Corporation
| Metric | CDNA (Apr 26, 2026) | DHR (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.98 | 34.61 |
| Forward P/E | 18.37 | 19.64 |
| PEG Ratio | -0.13 | 3.84 |
| Price to Sales (TTM) | 2.71 | 5.10 |
| Price to Book (MRQ) | 3.37 | 2.40 |
| Market Capitalization | ||
| Market Capitalization | $1.09B | $126.39B |
| Enterprise Value | $876.39M | $140.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.31 | 5.67 |
| Enterprise to EBITDA | -112.43 | 17.69 |
| Risk & Other Metrics | ||
| Beta | 2.54 | 0.99 |
| Book Value per Share (MRQ) | $5.95 | $74.32 |
Financial Statements Comparison: CareDx Inc. vs Danaher Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | CDNA (2025) | DHR (2025) |
|---|---|---|
| Revenue/Sales | 379.81M | 24.57B |
| Cost of Goods Sold | 123.24M | 10.05B |
| COGS % of Revenue | 32.4% | 40.9% |
| Gross Profit | 256.57M | 14.52B |
| Gross Margin | 67.6% | 59.1% |
| Research & Development | 71.43M | 1.60B |
| Operating Income (EBIT) | -25.07M | 4.69B |
| Operating Margin | -6.6% | 19.1% |
| EBITDA | 1.06M | 7.17B |
| EBITDA Margin | 0.3% | 29.2% |
| Pre-Tax Income | -21.08M | 4.23B |
| Pre-Tax Income % of Revenue | -5.6% | 17.2% |
| Income Tax | 271,000 | 633.00M |
| Income Tax % of Revenue | 0.1% | 2.6% |
| Net Income (Profit) | -21.35M | 3.61B |
| Profit Margin | -5.6% | 14.7% |
Balance Sheet & Liquidity Metrics
| Metric | CDNA (2025) | DHR (2025) |
|---|---|---|
| Cash & Equivalents | 65.43M | 4.62B |
| Total Current Assets | 257.13M | 12.76B |
| Total Current Assets % of Revenue | 67.7% | 51.9% |
| Total Current Liabilities | 89.85M | 6.81B |
| Total Current Liabilities % of Revenue | 23.7% | 27.7% |
| Long-Term Debt | 19.68M | 19.50B |
| Long-Term Debt % of Revenue | 5.2% | 79.4% |
| Total Shareholders Equity | 303.10M | 52.54B |
| Retained Earnings | -735.36M | 46.89B |
| Retained Earnings % of Revenue | -193.6% | 190.9% |
| Property, Plant & Equipment | 22.76M | 2.14B |
Cash Flow Statement Comparison
| Metric | CDNA (2025) | DHR (2025) |
|---|---|---|
| Operating Cash Flow | 47.02M | 5.64B |
| Operating Cash Flow % of Revenue | 12.4% | 23.0% |
| Capital Expenditures | N/A | -1.12B |
| Free Cash Flow | 35.44M | 5.26B |
| FCF Margin | 9.3% | 21.4% |
| Debt Repayment | N/A | -500.00M |
| Common Stock Repurchase | -87.77M | -3.09B |
Short Interest & Institutional Ownership Analysis
| Metric | CDNA | DHR |
|---|---|---|
| Shares Short | 6.42M | 6.94M |
| Short Ratio | 10.41 | 1.68 |
| Short % of Float | 12.84% | 1.10% |
| Shares Outstanding | 50.92M | 707.70M |
| Float Shares | 49.03M | 630.65M |
| % Held by Insiders | 4.37% | 10.78% |
| % Held by Institutions | 101.77% | 85.08% |
| % Held by Public | -6.14% | 4.14% |
Dividend Analysis & Yield Comparison: CareDx Inc. vs Danaher Corporation
| Metric | CDNA | DHR |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.28 |
| Last 12-Month Dividend Yield | N/A | 0.56% |
| 3-Year Avg Annual Dividend | N/A | $10.51 |
| 3-Year Avg Dividend Yield | N/A | 1.11% |
| 3-Year Total Dividends | N/A | $31.54 |
| Ex-Dividend Date | N/A | Dec 26, 2025 |